Pushpa 2 Worldwide Box Office Collection Day 56: Allu Arjun's Movie Earnings Fall After OTT Release Earns ₹1740 Cr
Date
1/29/2025 9:01:01 PM
(MENAFN- Live Mint) Pushpa: The Rule - Part 2 has achieved impressive worldwide box office numbers, with a total collection of ₹1740 crore. This includes ₹1232 crore from India's net collection, ₹1469 crore from India's gross earnings, and ₹270 crore from overseas markets.
In its first 56 days, the film performed exceptionally well, contributing to its continued success.
Also Read: Pushpa 2 OTT release confirmed! When and where to watch Allu Arjun's blockbuster movie
Here's a breakdown of the box office performance for Pushpa: The Rule - Part 2 over the last few days:
Day 51 (8th Friday): ₹0.3 Cr (Total: ₹0.12 Cr in Telugu, ₹0.18 Cr in Hindi) - A decline of 40%.
Day 52 (8th Saturday): ₹0.45 Cr (Total: ₹0.15 Cr in Telugu, ₹0.3 Cr in Hindi) - An increase of 50%.
Day 53 (8th Sunday): ₹1 Cr (Total: ₹0.4 Cr in Telugu, ₹0.6 Cr in Hindi) - A significant rise of 122.22%.
Day 54 (8th Monday): ₹0.3 Cr (Total: ₹0.12 Cr in Telugu, ₹0.18 Cr in Hindi) - A drop of 70%.
The film has already broken records with its theatrical version, and has surpassed 'Baahubali 2: The Conclusion' to become the highest-grossing Indian film ever.
Recently, actor Aamir Khan congratulated the team of 'Pushpa 2: The Rise' for its blockbuster success worldwide.
Also Read: Pushpa 2 Box Office collection Day 56: Allu Arjun film sees slight uptick in earnings ahead of its OTT release
Aamir Khan Productions took to X (formerly Twitter) and wrote, "Huge congratulations from AKP to the entire team of PUSHPA 2: THE RULE for the blockbuster success of the film! Wishing you continued success onwards and upwards. Love. Team AKP @mythriofficial @aryasukku @alluarjun @iamRashmika #FahadhFaasil."
MENAFN29012025007365015876ID1109146100
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.